STOCKHOLDERS EQUITY (Tables)

3 Months Ended

Mar. 31, 2025

STOCKHOLDERS' EQUITY

Schedule of share-based compensation

	Three Months Ended March 31,
	2025		2024
Stock options	$	152,512	$	15,911
RSUs		92,872		190,014
Total share-based compensation expense	$	245,384	$	205,925

Schedule of Stock options

	Three Months Ended
Grant-Date Weighted-Average Assumptions	March 31, 2025
Expected term (in years)		8.1
Risk-free interest rate		4.4	%
Expected dividend yield		0.0	%
Expected volatility		96.4	%
Fair value per share of options granted	$	1.54

						Weighted-Average
				Weighted-Average		Remaining		Aggregate
				Exercise Price		Contractual		Intrinsic
	Shares			Per Share		Term (in years)		Value
Options outstanding, December 31, 2024		4,330,000		$	0.23		3.7	$	6,652,700
Granted		470,000		$	1.81		-		-
Exercised		(322,500	)	$	0.23		-		-
Forfeited		(166,667	)	$	0.22		-		-
Expired		-			-		-		-
Options outstanding, March 31, 2025		4,310,833		$	0.41		4.3	$	7,731,574
Nonvested options, March 31, 2025		3,594,166		$	0.44		4.7	$	6,317,574
Vested and exercisable options, March 31, 2025		716,667		$	0.23		2.4	$	1,414,000

Schedule of Restricted stock units

				Weighted-Average
				Grant-Date
				Fair Value
	Shares			Per Share
Nonvested shares at December 31, 2024		2,090,000		$	0.24
Granted		250,000		$	1.78
Vested and issued		(825,000	)	$	0.22
Forfeited		-			-
Nonvested shares at March 31, 2025		1,515,000		$	0.51

Schedule of Common Stock Warrants

	Number of			Weighted Average
	warrants			Exercise Price
Balance outstanding at December 31, 2024		10,142,215		$	0.77
Exercised		(948,750	)		0.85
Balance outstanding at March 31, 2025		9,193,465		$	0.76

Schedule Of Warrants outstanding

Number of warrants	Exercise Price	Expiration Date	Remaining life (years)
2,085,715	$0.46	1/27/2026	0.83
6,301,250	$0.85	8/3/2026	1.34
806,500	$0.85	2/1/2026	0.84
9,193,465